Patient-reported Outcomes in a French Nationwide Survey of Inflammatory Bowel Disease Patients
- 11 August 2016
- journal article
- research article
- Published by Oxford University Press (OUP) in Journal of Crohn's and Colitis
- Vol. 11 (2) , 165-174
Abstract
Background: Patient reported-outcomes (PROs) are a major therapeutic goal in inflammatory bowel disease (IBD). Methods: Between January to June 2014, patients affiliated with the French national IBD association filled out six self-questionnaires: quality of life (QoL, according to the Short Inflammatory Bowel Disease Questionnaire [SIBDQ] and the Short-Form-36 Questionnaire [SF-36] v2), fatigue (the Functional Assessment of Chronic Illness Therapy-Fatigue [FACIT-F]), work productivity (the Work Productivity and Activity Impairment [WPAI] questionnaire), disability [the Inflammatory Bowel Disease Disability Index], and anxiety/depression (the Hospital Anxiety and Depression scale [HADS]). Associated factors were identified by univariate and multivariate logistic regression analyses. Results: Datasets were obtained from 1185 IBD patients. Around half of patients reported poor QoL (SIBDQ7: 30.3%) and/or moderate (22.4%) or severe (11.9%) disability. About half of them reported presenteeism and moderate-to-severe loss of work productivity and loss of activity. Poor QoL, severe fatigue, severe disease-related disability and/or high WPAI were all associated with female gender, unemployment and disease activity. Poor QoL, severe fatigue and high WPAI were also associated with the use of tumour necrosis factor antagonists. A history of surgery was associated with poor QoL, whereas age was associated with severe fatigue. Severe depression was associated with female gender and disease activity. Conclusion: The disease burden is very high in IBD, with poor QoL, fatigue, work impairment and depression in half of patients. Marked disability and anxiety were reported by one third of patients.Keywords
This publication has 31 references indexed in Scilit:
- Validation of the Inflammatory Bowel Disease Disability Index in a population-based cohortGut, 2015
- Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE): Determining Therapeutic Goals for Treat-to-TargetAmerican Journal of Gastroenterology, 2015
- Patient-Reported Outcomes as Primary End Points in Clinical Trials of Inflammatory Bowel DiseaseClinical Gastroenterology and Hepatology, 2014
- Fatigue is highly associated with poor health‐related quality of life, disability and depression in newly‐diagnosed patients with inflammatory bowel disease, independent of disease activityAlimentary Pharmacology & Therapeutics, 2014
- Validation of the Functional Assessment of Chronic Illness Therapy‐Fatigue (FACIT‐F) in patients with inflammatory bowel diseaseAlimentary Pharmacology & Therapeutics, 2011
- Development of the first disability index for inflammatory bowel disease based on the international classification of functioning, disability and healthGut, 2011
- Systematic review: fatigue in inflammatory bowel diseaseAlimentary Pharmacology & Therapeutics, 2010
- Measuring fatigue and other anemia-related symptoms with the Functional Assessment of Cancer Therapy (FACT) measurement systemJournal of Pain and Symptom Management, 1997
- The MOS 36-ltem Short-Form Health Survey (SF-36)Medical Care, 1992
- The Hospital Anxiety and Depression ScaleActa Psychiatrica Scandinavica, 1983